Common use of Preferred Drug List Clause in Contracts

Preferred Drug List. To be eligible for the Supplemental Rebates specified in Attachment B: a) State shall place and maintain Covered Product(s) on the Preferred Drug List, it being agreed that utilization shall be eligible for the State Supplemental Rebate only in quarters in which Covered Product(s) is listed on the Preferred Drug List; and b) State shall place Covered Product(s) in an advantaged position relative to non-preferred Competitive Product(s) regarding Preferred Drug List status, and c) Depending on the designated preferred tier, the State shall place Covered product(s) in an advantaged position relative to other preferred products (Step Care). Non-Preferred and Step Care drugs may be subject to prior authorization. Criteria for approving prior authorization will be the responsibility of the DUR Committee. These criteria will meet generally accepted clinical standards of practice for the proper use of drugs, and d) State shall have on file the fully executed CMS Exemption Letter, attached hereto as Exhibit C and incorporated by reference.

Preferred Drug List. To be eligible for the Supplemental Rebates specified in Attachment B: a) State shall place and maintain Covered Product(s) Product on the Preferred Drug List, it being agreed that utilization shall be eligible for the State Supplemental Rebate only in quarters in which Covered Product(s) Product is listed on the Preferred Drug List; and b) State shall place Covered Product(s) Products in an advantaged position relative to non-preferred Competitive Product(s) Products regarding Preferred Drug List status, and c) Depending on the designated preferred tier, the State shall place Covered product(s) products in an advantaged position relative to other preferred products (Step Care). Non-Preferred and Step Care drugs may be subject to prior authorization. Criteria for approving prior authorization will be the responsibility of the DUR Committee. These criteria will meet generally accepted clinical standards of practice for the proper use of drugs, and d) State shall have on file the fully executed CMS Exemption Letter, attached hereto as Exhibit C and incorporated by reference.

Preferred Drug List. To be eligible for the Supplemental Rebates specified in Attachment B: a) State shall place and maintain Covered Product(s) Product on the Preferred Drug List, it being agreed that utilization shall be eligible for the State Supplemental Rebate only in quarters in which Covered Product(s) Product is listed on the Preferred Drug List; and b) State shall place Covered Product(s) Products in an advantaged position relative to non-non- preferred Competitive Product(s) Products regarding Preferred Drug List status, and c) Depending on the designated preferred tier, the State shall place Covered product(s) products in an advantaged position relative to other preferred products (Step Care). Non-Preferred and Step Care drugs may be subject to prior authorization. Criteria for approving prior authorization will be the responsibility of the DUR Committee. These criteria will meet generally accepted clinical standards of practice for the proper use of drugs, andand Deleted: .¶ d) State shall have on file the fully executed CMS Exemption Letter, attached hereto as Exhibit C and incorporated by reference.. Formatted: Bullets and Numbering

Preferred Drug List. To be eligible for the Supplemental Rebates specified in Attachment B: a) State shall place and maintain Covered Product(s) on the Preferred Drug List, it being agreed that utilization shall be eligible for the State Supplemental Rebate only in quarters in which Covered Product(s) is listed on the Preferred Drug List; and b) State shall place Covered Product(s) in an advantaged position relative to non-preferred Competitive Product(s) regarding Preferred Drug List status, and c) Depending on the designated preferred tier, the State shall place Covered product(sProduct(s) in an advantaged position relative to other preferred products (Step Care). Non-Preferred and Step Care drugs may be subject to prior authorization. Criteria for approving prior authorization will be the responsibility of the DUR Committee. These criteria will meet generally accepted clinical standards of practice for the proper use of drugs, and d) State shall have on file the fully executed CMS Exemption Letter, attached hereto as Exhibit C and incorporated by reference.